#USA #Salt Lake City #Co-Diagnostics #Trade Mission #WTC Utah

Co-Diagnostics Engages in European Trade Mission

Co-Diagnostics, Inc. (Nasdaq-CM: CODX), a leader in molecular diagnostics, is embarking on an important trade mission across Switzerland and Germany alongside Utah Governor Spencer Cox and the World Trade Center (WTC) Utah. Scheduled for April 13-22, this mission aims to enhance business relationships and expand Co-Diagnostics' international footprint in some of Europe’s most significant economic regions.

Strengthening International Relations

As stated by Co-Diagnostics' CEO, Dwight Egan, the mission’s goal is to strengthen strategic partnerships while also contributing positively to the community. Switzerland and Germany are recognized as global hubs for technological innovation, diagnostics, and financial sectors, making them ideal locations for Co-Diagnostics to explore collaborative opportunities. The itinerary includes visits to leading institutions such as Roche Diagnostics, UBS, and the Zurich Innovation Park, among others. By engaging with these global leaders, Co-Diagnostics aims to reinforce its commercial, diplomatic, and institutional connections within Europe.

Focus on Diagnostic Advancements

Integral to this mission is the introduction of Co-Diagnostics’ real-time PCR point-of-care diagnostic platform, which is now poised for 510(k) submission to the U.S. Food and Drug Administration. The company is excited about potentially groundbreaking innovations that can enhance diagnostic testing, particularly in point-of-care settings. A significant portion of the trade mission will be spent in Switzerland, where executives will have the opportunity to network and establish business relations before continuing to Munich for the European Society of Clinical Microbiology and Infectious Disease (ESCMID Global) 2026 Congress.

Highlights of the Itinerary

The mission's schedule is packed with activity, featuring site visits to prestigious academic facilities, networking opportunities, and meetings with industry leaders. These engagements are expected to yield fruitful discussions around collaborative research and development initiatives. The presence of companies like Roche Diagnostics, known worldwide for their diagnostic systems, adds an exciting dimension to the mission.

Global Expansion Efforts

Following the trade mission, Co-Diagnostics is also looking forward to accelerating its global strategy, which includes recent international joint ventures in countries such as India and the Kingdom of Saudi Arabia. These efforts are part of a broader strategy to enhance the company’s capacity to deliver innovative diagnostic solutions worldwide.

The trade mission organized by WTC Utah is not just a platform for expanding business; it is also a gateway for Utah companies to connect with global resources. This initiative aligns with Utah's goal to promote economic growth through international trade, thereby facilitating new opportunities and partnerships for local businesses, including Co-Diagnostics.

In conclusion, Co-Diagnostics' participation in this trade mission marks a significant step towards fostering international collaborations that will advance both the company's growth and the diagnostic sector as a whole. As the world becomes increasingly interconnected, initiatives like this are essential for staying at the forefront of innovation and market relevance.

Disclaimer: The Co-Dx PCR platform and associated tests are currently under regulatory review and are not yet available for commercial sale.